Recovery from CMV esophagitis after allogeneic bone marrow transplantation using non-myeloablative conditioning: The role of immunosuppression

Journal of Clinical Virology

Volumn 34, Issue 3, 2005, Pages 219-223

  Fiegl, Michael ^a   Gerbitz, Armin ^a,b   Gaeta, Antonia ^b   Campe, Hartmut ^c   Jaeger, Gundula ^c   Kolb, Hans Jochem ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Allogeneic bone marrow transplantation; Cytomegalovirus; Esophagitis; Immunosuppression; Paroxysmal nocturnal hemoglobinuria

Indexed keywords

ACICLOVIR; CIDOFOVIR; CYCLOSPORIN A; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; RAPAMYCIN; THYMOCYTE ANTIBODY;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE SEVERITY; DNA DETERMINATION; DRUG CYTOTOXICITY; DRUG DOSE REDUCTION; ESOPHAGITIS; ESOPHAGUS BIOPSY; FEMALE; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL EXAMINATION; MUCOSA INFLAMMATION; NONMYELOABLATIVE CONDITIONING; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATIENT REFERRAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION DOSE; WOUND HEALING IMPAIRMENT;

ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS INFECTIONS; DRUG THERAPY, COMBINATION; ESOPHAGITIS; FEMALE; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 26444615101     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2005.07.001     Document Type: Article

References (15)

1. M. Boeckh, W. Leisenring, S.R. Riddell, R.A. Bowden, M.L. Huang, and D. Myerson Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity Blood 101 2003 407 414
2. M. Boeckh, M. Huang, J. Ferrenberg, T. Stevens-Ayers, L. Stensland, and W.G. Nichols Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR J Clin Microbiol 42 2004 1142 1148
3. A.E. Broers, R. van der Holt, J.W. van Esser, J.W. Gratama, S. Henzen-Logmans, and V. Kuenen-Boumeester Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation Blood 95 2000 2240 2245
4. F.S. Buckner, and C. Pomeroy Cytomegalovirus disease of the gastrointestinal tract in patients without AIDS Clin Infect Dis 17 1993 644 656
5. S. Chou, S. Guentzel, K.R. Michels, R.C. Miner, and W.L. Drew Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates J Infect Dis 172 1995 239 242
6. J.M. Goodrich, M. Mori, C.A. Gleaves, C. Du Mond, M. Cays, and D.F. Ebeling Early treatment with ganciclovir to prevent cytomegalovirs disease after allogeneic bone marrow transplantation N Engl J Med 325 1991 1601 1607
7. M. Guba, P. von Breitenbuch, M. Steinbauer, G. Koehl, S. Flegel, and M. Hornung Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor Nat Med 8 2002 128 135
8. S.F. Lacey, D.J. Diamond, and J.A. Zaia Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants Biol Blood Marrow Transplant 10 2004 433 447
9. H.T. Maecker, and V.C. Maino Analyzing T-cell response to cytomegalovirus by cytokine flow cytometry Hum Immunol 65 2004 493 499
10. K.E. Monkemuller, and C.M. Wilcox Esophageal ulcer caused by cytomegalovirus: resolution during combination antiretroviral therapy for acquired immunodeficiency syndrome South Med J 93 2000 818 820
11. F. Parente, and G. Bianchi Porro Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group Am J Gastroenterol 93 1998 317 322
12. A.O. Qamruddin, B.A. Oppenheim, M. Guiver, K.J. Mutton, and R. Chopra Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: analysis of potential risk factors for CMV infection Bone Marrow Transplant 27 2001 301 306
13. B. Salzberger, A. Stoehr, W. Heise, G. Fatkenheuer, A. Schwenk, and C. Franzen Foscarnet and ganciclovir combination therapy for CMV disease in HIV-infected patients Infection 22 1994 197 200
14. C.M. Wilcox, R.F. Straub, and D.A. Schwartz Cytomegalovirus esophagitis in AIDS: a prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome Am J Med 98 1995 169 176
15. J.A. Zaia Prevention and management of CMV-related problems after hematopoietic stem cell transplantation Bone Marrow Transplant 29 2002 633 638